Table 4.
Groups | T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 |
---|---|---|---|---|---|---|---|---|
HR | ||||||||
P | 67±13 | 60±10¶ | 68±10 | 61±10¶ | 62±8 | 60±10* | 61±7* | 66±7 |
K | 72±13 | 65±11* | 70±8 | 68±8 | 65±10* | 62±9¶ | 64±8 | 67±8 |
MAP | ||||||||
P | 88±15 | 69±11¶ | 85±19 | 78±16* | 74±14¶ | 77±12¶ | 91±15 | 98±11* |
K | 96±9 | 89±14 | 104±18* | 99±17 | 91±16 | 88±14 | 98±18 | 100±13 |
CVP | ||||||||
P | 6.7±2.9 | 8.3±1.6* | 9.3±2.8¶ | 9.3±2.6* | 9.4±2.4¶ | 8.8±2.4* | 9.6±3.2* | 9.4±2.1¶ |
K | 7.5±2,7 | 9±2.6* | 10.4±2.0¶ | 9.4±2.2* | 9.7±2.4* | 9.7±2.7* | 10.4±3.4* | 9.6±3.6 |
PAP | ||||||||
P | 15±5 | 17±4* | 17±4* | 17±4 | 16±3 | 16±3 | 17±3* | 17±3* |
K | 15±4 | 18±4* | 20±3¶ | 18±3* | 18±3* | 17±3* | 19±4* | 18±5* |
PCWP | ||||||||
P | 11±4 | 12±4 | 13±3* | 12±4 | 11±3 | 11±3 | 13±3* | 13±3* |
K | 11±4 | 13±3 | 15±3* | 13±2 | 14±3* | 13±3 | 15±3* | 14±5* |
CI | ||||||||
P | 2.2±0.3 | 2.1±0.4 | 2.2±0.4 | 2.1±0.5 | 1.9±0.4 | 2.0±0.4 | 2.0±0.4 | 2.0±0.4 |
K | 2.2±0.6 | 1.8±0.4* | 1.9±0.5 | 1.8±0.6 | 1.7±0.5¶ | 1.6±0.5¶ | 1.6±0.6¶ | 1.9±0.4 |
SVRI | ||||||||
P | 2917±568 | 2341±567* | 2755±721 | 2651±810 | 2664±809 | 2765±636 | 3248±717 | 3540±851¶ |
K | 3465±1025 | 3658±1337 | 3991±1151 | 4002±1153 | 4042±1537 | 4100±1896 | 4633±1947¶ | 4678±1030¶ |
PVRI | ||||||||
P | 141±98 | 187±78* | 160±66 | 171±94 | 195±49* | 193±87* | 164±60 | 174±75 |
K | 168±78 | 234±99* | 189±100 | 217±103 | 180±99 | 233±78* | 220±90 | 215±80¶ |
SVI | ||||||||
P | 34±6 | 37±7 | 33±5 | 35±7 | 32±5 | 37±5 | 32±6 | 32±6 |
K | 31±8 | 29±8 | 29±6 | 28±8 | 28±8 | 29±8 | 26±9 | 28±8 |
LVSWI | ||||||||
P | 36±6 | 28±8¶ | 32±9* | 32±9* | 27±8¶ | 30±7¶ | 34±8 | 37±8 |
K | 36±9 | 30±8* | 34±10 | 34±13 | 31±9 | 29±9¶ | 29±11* | 28±9* |
RVSWI | ||||||||
P | 9.7±5.4 | 10.5±6.3 | 7.0±2.9* | 9.3±3.9 | 7.3±3.3 | 8.3±3.6 | 7.0±3.7 | 6.9±5.2* |
K | 3.8±1.8 | 3.3±1.5 | 3.3±1.4 | 3.2±1.7 | 2.8±1.4 | 2.8±1.4* | 2.8±1.5 | 2.6±1.5* |
P: Group P (patients who were given propofol during induction); K: Group K (patients who were given ketamine during induction); HR: heart rate (beat. min−1); MAP: Mean arterial pressure (mmHg); CVP: Central venous pressure (mmHg); PAP: Mean pulmonary artery pressure (mmHg); PCWP: Mean pulmonary capillary wedge pressure (mmHg); CI: Cardiac index (L.min−1.m−2); SVI: Stroke volume index (ml.m−2); SVRI and PVRI: Systemic and pulmonary vascular resistance indices (dyne.s.cm−5.m−2); LVSWI and RVSWI: Left and right ventricular stroke work indices (g.m.m−2); T1: Prior to induction of anesthesia, while the patient was awake; T2: one minute after induction; T3: one minute after intubation; T4: three minutes after intubation; T5: five minutes after intubation; T6: 10 minutes after intubation; T7: one minute after skin incision; T8: one minute after sternotomy.
p<0.05 compared with T1;
p<0.01 compared with T1;
P<0.001 compared with T1